Immutep Limited (IMMP)
NASDAQ: IMMP
· Real-Time Price · USD
1.85
-0.01 (-0.54%)
At close: May 09, 2025, 3:59 PM
1.93
4.32%
After-hours: May 09, 2025, 05:03 PM EDT
-0.54% (1D)
| Bid | 1.78 |
| Market Cap | 269.28M |
| Revenue (ttm) | 4.88M |
| Net Income (ttm) | -43.87M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -7.71 |
| Forward PE | -4.87 |
| Analyst | Buy |
| Ask | 2.08 |
| Volume | 135,926 |
| Avg. Volume (20D) | 261,862 |
| Open | 1.86 |
| Previous Close | 1.86 |
| Day's Range | 1.80 - 1.89 |
| 52-Week Range | 1.32 - 3.34 |
| Beta | 1.48 |
About IMMP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMMP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMMP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 days ago
+45.61%
Immutep shares are trading higher after the compan...
Unlock content with
Pro Subscription
5 months ago
+11.76%
Immutep shares are trading higher after the company announced the presentation of new data from EFTISARC-NEO, a Phase II investigator-initiated trial of eftilagimod alpha in combination with radiotherapy plus KEYTRUDA for patients with soft tissue sarcoma, at the CTOS 2024 Annual Meeting.
